Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Synonyms: Rivastigmine tartrate; ENA-713; Ethylmethyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester; N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate; S-Rivastigmine tartrate
Molecular Formula: C14H22N2O2 · C4H6O6
Molecular Weight: 400.42
Linear Structural Formula: C14H22N2O2 · C4H6O6
Biochem Physiol Actions: Rivastigmine is an orally available, brain penetrant, reversible cholinesterase inhibitor that enhances cognitive function in patients with Alzheimer's and Parkinson's diseases. Rivastigmine inhibits both butyrylcholinesterase and acetylcholinesterase.
Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.